STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLNN
  4. [Form 4] Clene Inc. Insider Trading Activity

Clene Inc. (CLNN) director granted 3,514 stock options at $4.19 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Clene Inc. director Reed N. Wilcox reported a grant of stock options for 3,514 shares of common stock on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan. The options have an exercise price of $4.19 per share, vest immediately upon grant, and expire on August 12, 2036. Following this award, Wilcox holds 3,514 options directly.

Positive

  • None.

Negative

  • None.
Insider WILCOX REED N
Role Director
Type Security Shares Price Value
Grant/Award stock option F1 3,514 $0.00 $0.00
Holdings After Transaction: stock option — 3,514 shares (Direct)
Footnotes (1)
  1. F1. This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
Options granted 3,514 options Stock option grant to director Reed N. Wilcox on August 13, 2026
Exercise price $4.19 per share Exercise price of options for 3,514 shares of common stock
Expiration date August 12, 2036 Expiration of stock options granted under Amended 2020 Stock Plan
Options held after grant 3,514 options Total options directly held by Reed N. Wilcox following this transaction
stock option financial
"This option was granted on August 13, 2026 as an option for 3,514 shares"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Amended 2020 Stock Plan financial
"shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan"
vest immediately upon grant financial
"at an exercise price of $4.19 per share. The options vest immediately upon grant."

FAQ

What insider transaction did Clene Inc. (CLNN) report for Reed N. Wilcox?
Clene Inc. reported that director Reed N. Wilcox received a grant of stock options for 3,514 shares of common stock on August 13, 2026 as part of equity compensation.

What is the exercise price of Reed N. Wilcox’s new Clene (CLNN) stock options?
The granted options have an exercise price of $4.19 per share. This is the price at which Wilcox can purchase Clene Inc. common stock upon exercising the options before they expire.

When do Reed N. Wilcox’s Clene (CLNN) options vest and expire?
The options vest immediately upon grant and carry an expiration date of August 12, 2036. Wilcox can exercise them any time after grant and before the expiration date, subject to plan terms.

Under which plan were the new Clene (CLNN) stock options granted to Reed N. Wilcox?
The options were granted under the Clene Inc. Amended 2020 Stock Plan. This equity incentive plan governs the terms of the award, including vesting, exercise, and expiration conditions.

How many Clene (CLNN) options does Reed N. Wilcox hold after this transaction?
After the reported grant, Reed N. Wilcox holds 3,514 stock options directly. Each option is exercisable for one share of Clene Inc. common stock at an exercise price of $4.19 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WILCOX REED N
(Last)(First)(Middle)
6550 SOUTH MILLROCK DRIVE
SUITE G50
(Street)
SALT LAKE CITY UTAH 84121
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
stock option$4.1908/13/2026A3,514 (1)08/12/2036common stock3,514$03,514D
Explanation of Responses:
1. This option was granted on August 13, 2026 as an option for 3,514 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.
/s/ Jerome T. Miraglia POA08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR